Clopidogrel versus Aspirin Monotherapy Beyond 1 Year After PCI: STOPDAPT-2 5-Year Results.
Hirotoshi Watanabe,Takeshi Morimoto,Masahiro Natsuaki,Ko Yamamoto,Yuki Obayashi,Ryusuke Nishikawa,Kenji Ando,Koh Ono,Kazushige Kadota,Satoru Suwa,Itsuro Morishima,Ruka Yoshida,Yoshiki Hata,Masaharu Akao,Masahiro Yagi,Nobuhiro Suematsu,Yoshihiro Morino,Takafumi Yokomatsu,Itaru Takamisawa,Toshiyuki Noda,Masayuki Doi,Hideki Okayama,Yuichi Nakamura,Kiyoshi Hibi,Hiroki Sakamoto,Teruo Noguchi,Takeshi Kimura Journal of the American College of Cardiology(2023)
摘要
Clopidogrel might be an attractive alternative to aspirin with a borderline ischemic benefit beyond 1-year after PCI.
更多查看译文
AI 理解论文
溯源树
样例